Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

496
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
496
Antibody Actions01:26

Antibody Actions

1.1K
Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
1.1K
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

68.3K
Overview
68.3K
Cross-reactivity00:42

Cross-reactivity

31.1K
Overview
31.1K
Vaccinations01:51

Vaccinations

44.5K
Overview
44.5K
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

1.4K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
1.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dual-Functional Metal Interlayer Enables High-Quality GaN Epitaxy and Low-Damage Transfer Towards Flexible Optoelectronics.

Small methods·2026
Same author

CIRBP maintains skeletal muscle mitochondrial energy homeostasis via mt-ATP6 to ameliorate sarcopenia.

Biochemical and biophysical research communications·2026
Same author

High encoding-sensitivity vision sensor with complementary nonlinear neuromorphic computing.

Nature communications·2026
Same author

Efficacy of Pimpinella anisum L. in Menopausal Women with Psychological Symptoms: A Randomized Controlled Study Integrated with Machine Learning Analysis.

Current pharmaceutical design·2026
Same author

SlGRAS17 negatively regulates chlorophyll biosynthesis in tomato.

Plant physiology·2026
Same author

Post-stroke rehabilitative mechanisms in individualized fatigue level-controlled treadmill training in rats.

Neural regeneration research·2026

Related Experiment Video

Updated: Jul 5, 2025

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes
07:59

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes

Published on: March 25, 2014

15.0K

Blocking Superantigen-Mediated Diseases: Challenges and Future Trends.

Pengbo Wang1, Zina Fredj1, Hongyong Zhang1

  • 1CenBRAIN Neurotech, School of Engineering, Westlake University, Hangzhou 310030, China.

Journal of Immunology Research
|January 25, 2024
PubMed
Summary

Superantigens cause immune diseases by overactivating T cells. Drug delivery methods offer a promising strategy to target and block these superantigens, minimizing side effects for safer treatment of related immune disorders.

More Related Videos

Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes
08:52

Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes

Published on: July 26, 2019

8.2K
Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
06:03

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays

Published on: September 20, 2024

1.3K

Related Experiment Videos

Last Updated: Jul 5, 2025

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes
07:59

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes

Published on: March 25, 2014

15.0K
Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes
08:52

Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes

Published on: July 26, 2019

8.2K
Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
06:03

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays

Published on: September 20, 2024

1.3K

Area of Science:

  • Immunology
  • Microbiology
  • Pharmacology

Background:

  • Superantigens are microbial virulence factors triggering immune diseases like rheumatoid arthritis and multiple sclerosis.
  • They bind directly to MHC II, activating T cells and causing cytokine storms.
  • Current treatments like antibodies and peptides have limited success due to superantigen complexity.

Purpose of the Study:

  • To review drug delivery methods for targeting superantigens.
  • To explore strategies for blocking superantigens while reducing adverse effects.
  • To present a potential therapeutic approach for superantigen-mediated diseases.

Main Methods:

  • Review of existing literature on superantigens and therapeutic strategies.
  • Analysis of drug delivery systems for targeted intervention.
  • Evaluation of CD28 mimic peptides and their limitations.

Main Results:

  • Superantigens bypass intracellular processing, directly activating T cells.
  • CD28 mimic peptides show potential but carry risks of reduced T-cell activity and increased infection.
  • Drug delivery methods offer precise targeting of superantigens.

Conclusions:

  • Drug delivery systems present a viable strategy for managing superantigen-mediated diseases.
  • This approach aims to enhance therapeutic efficacy and safety.
  • Targeted blocking of superantigens can mitigate immune overactivation and associated pathologies.